Mercer Global Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
BIP
VCM
MA
RHJA
Mercer Global Advisors's UTMD Position: Q1 2026 in Review
Mercer Global Advisors increased its Utah Medical Products (UTMD) stake by 14% in Q1 2026, buying an estimated $67.6K and bringing the position to 8,878 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.
Mercer Global Advisors first reported a position in UTMD in Q1 2021 and has held it in 21 quarters since. The position peaked at $973K in Q4 2022. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.
- Mercer Global Advisors held 8,878 shares of Utah Medical Products worth $550K as of Q1 2026.
- Mercer Global Advisors bought 1,073 Utah Medical Products shares in Q1 2026, an estimated $67.6K.
- Utah Medical Products made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1916 holding.
- Mercer Global Advisors first reported a position in Utah Medical Products in Q1 2021 and has held it in 21 quarters since.
- Mercer Global Advisors's Utah Medical Products position peaked at $973K in Q4 2022.
- 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.
Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.